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Excretion of amino acids by yeast cells was reported long ago but has not been characterized in molecular
terms. It is typically favored by overproduction of the amino acid and/or impairment of its uptake. Here we
describe the construction of a yeast strain excreting threonine and homoserine. Using this excretor strain, we
then applied a reverse-genetics approach and found that the transporter encoded by the YNL065w/AQR1 gene,
a protein thought to mediate H antiport, is involved in homoserine and threonine excretion. Furthermore,
overexpression of AQR1 led to increased excretion of several amino acids (alanine, aspartate, and glutamate)
known to be relatively abundant in the cytosol. Transcription of the AQR1 gene is induced severalfold by a
number of amino acids and appears to be under the negative control of Gcn4. An Aqr1-green fluorescent
protein fusion protein is located in multiple internal membrane structures and appears to cycle continuously
between these compartments and the plasma membrane. The Aqr1 sequence is significantly similar to the
vesicular amine transporters of secretory vesicles of neuronal cells. We propose that Aqr1 catalyzes transport
of excess amino acids into vesicles, which then release them in the extracellular space by exocytosis.
Uptake of amino acids across the plasma membrane occurs
in all living cells. Many genes encoding amino acid transporters
have been cloned from a wide variety of organisms, and on the
basis of primary sequence analyses, they have been classified in
just a few families (58, 66). Amino acid uptake systems are
generally used by cells to scavenge amino acids from the en-
vironment for use in protein synthesis and/or as sources of
nitrogen, carbon, and/or energy. In animals, several amino
acids also act as neurotransmitters whose re-uptake from the
synaptic cleft involves specific transporters (47, 55). While
amino acid import has been investigated extensively, much less
is known today about systems involved in amino acid excretion.
The existence of proteins involved in this excretion may at first
sight be surprising, given the crucial role played by amino acids
in cell metabolism. However, several studies suggest that
amino acid excretion may be a more widespread process than
anticipated. For instance, studies of bacteria have shown that
excretion of amino acids can occur when the central metabo-
lism is imbalanced: e.g., when carbon and energy sources are
present in excess and massively used by the cells but growth is
limited by lack of an essential nutrient or other compound.
Metabolic overflow is, for instance, a prerequisite to effective
L-glutamate acid production by Corynebacterium glutamicum.
It is induced in biotechnological processes by limiting the for-
mation of biotin, by adding antibiotics or inhibitors of fatty acid
biosynthesis, or by introducing a fatty acid or glycerol auxot-
rophy (35). Excretion of amino acids is also observed under
conditions of limited peptide catabolism (10). For instance,
L-lysine excretion is observed in bacteria using L-lysine-con-
taining peptides as a carbon source but lacking L-lysine-de-
grading enzymes (19). Deregulated anabolism is yet another
situation favoring excretion of amino acids by bacteria (10). In
support of the view that export of amino acids is physiologically
relevant under at least some conditions, genes encoding mem-
brane proteins specifically involved in amino acid excretion
have been cloned from bacteria like C. glutamicum and Esch-
erichia coli (16). These studies have led to defining completely
novel transporter families, one of which appears conserved
throughout all kingdoms of life (58, 67).
Studies using yeast as a model have shown that this simple
eukaryote can also release detectable amounts of amino acids
into the medium. This was typically observed with cells pro-
ducing unusually large amounts of an amino acid as a result of
deregulated anabolism and impaired catabolism (30). It has
also been reported that mutants auxotrophic for a specific
amino acid or for pyrimidine excrete a number of different and
unrelated amino acids once the cells are transferred to a me-
dium lacking the required compound, such conditions causing
growth arrest (30). These studies have also shown that excre-
tion is generally more pronounced if cells are defective in the
permeases that mediate high-affinity uptake of the excreted
compound (29, 30, 41, 45). This has led to the notion that
high-affinity permeases may play an important role in retention
of intracellular compounds (31). Yet the transport mechanisms
involved in excretion of amino acids by yeast remain unknown.
In pluricellular organisms, transfer of amino acids between
tissues involves rounds of transport out of and into the cell. For
instance, root plant cells are known to release amino acids into
the xylem sap for subsequent distribution to different organs,
but the mechanism of this excretion remains uncharacterized.
Similarly, leaf cells excrete amino acids into the apoplast (sur-
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rounding cell walls) via mechanisms that remain to be eluci-
dated, after which these amino acids are incorporated into
phloem cells for supply to sink organs (40). In mammals, the
directional transfer of several amino acids between cells plays
an important role in metabolism and signaling (12). One ex-
ample is the glutamine-glutamate cycle in the nervous system.
Glutamate is first loaded into secretory vesicles via the
VGLUT vesicular glutamate/H antiporter (54). After its re-
lease from nerve terminals by regulated exocytosis, glutamate
is taken up by astrocytes surrounding the synapse and con-
verted to glutamine. Glutamine is then excreted by the astro-
cytes and taken up by neurons, which reconvert it to glutamate.
Excretion of glutamine by astrocytes is mediated by the system
1 protein (SN1), a glutamine-Na/H antiporter (13) also
expressed in liver. This cycle illustrates the importance of the
two modes of amino acid release by animal cells: (i) by a
cell-surface-associated transporter and (ii) via exocytosis, the
latter requiring prior loading of the vesicle catalyzed by an
amino acid/H-antiporter.
In this study, we report the first molecular characterization
in yeast of a protein involved in excretion of amino acids. This
protein (Aqr1/Ynl065w) (62) is a member of the multidrug
resistance transporter family, a category of proteins thought to
mediate H antiport (28, 57). Aqr1 is apparently involved in
excretion of amino acids present at high concentrations in the
cytosol. Interestingly, Aqr1 is located in multiple internal-
membrane structures and appears to cycle between these com-
partments and the cell surface. According to one model of
Aqr1-dependent amino acid excretion discussed here, the pro-
tein would load internal vesicles with amino acids, these being
subsequently released into the external medium by exocytosis.
MATERIALS AND METHODS
Strains and growth conditions. All Saccharomyces cerevisiae strains used in
this work (Table 1) are isogenic with 1278b (7), except for strain F4. Cells were
grown on rich (YPD) or minimal buffered medium (pH 6.1, except when men-
tioned otherwise) (38), with 3% glucose as the carbon source except when noted
otherwise. Nitrogen sources were added as indicated to the following final con-
centrations: proline, 0.1%; urea, 0.1%; (NH4)2SO4, 0.25%; or L-threonine (Thr),
1 to 10 mM. When necessary, cultures of auxotrophic strains were supplemented
with uracil (0.14 mM), Thr (0.25 to 10 mM), or L-homoserine (Hom) (0.025 to
12.5 mM). In the AQR1/YNL065w overexpression experiment, cells were grown
on minimal ammonium medium plus 5-g/ml doxycycline hydrochloride. The
sensitivity of strains 23344c (ura3), JA324 (ura3 aqr1::lacZ), JA248 (gap1
agp1 gnp1), and IVU271 (gap1 agp1 gnp1 aqr1) to hygromycin B (0.01
to 0.1 M), tetramethylammonium (0.02 to 0.2 M), and LiCl (0.01 to 0.1 M) was
assessed by comparative growth tests on YPD solid medium.
Construction of mutant strains. The gnp1, thr1, hom3, aqr1, qdr1, and
thr1 null mutations were introduced in yeast strains by the PCR-based gene
deletion method and the disruption cassette of plasmid pUG6 (33). The same
procedure was used to replace with lacZ the coding sequences of the AQR1,
QDR3, and QDR1 genes in strain 23344c, except that the template DNA for PCR
amplification was plasmid pUG6-lacZ (8). The qdr3 null mutation was intro-
duced into strain JA248 by transformation with the NotI restriction fragment of
the pYORC-YBR043c plasmid containing the kanMX marker gene flanked by
the 5 and 3 regions of the open reading frame YBR043c/QDR3 (62). The JA551
strain expressing Aqr1 fused at its extreme C terminus to the GFP preceded by
a five-glycine-alanine linker was isolated by integration of a DNA fragment
generated by PCR with plasmid GA5-GFP65T-KanMX6 as the template DNA.
Yeast cells were transformed by the method of Gietz et al. (27). All gene
modifications were checked by PCR tests. All oligonucleotides used for the
construction of strains are listed in Table 2.
Plasmid constructions. All procedures for DNA manipulation were standard
(5, 59). The centromere-based (pMACR7) and 2m-based (pYH3-R2) plasmids
containing the mutant HOM3-R allele have been described elsewhere (21;
Velasco et al., unpublished data). Plasmid pIVU13 derives from the yeast ex-
pression vector pCM190 (24) and contains the AQR1 coding region under con-
trol of the tetO promoter. The centromere-based plasmid (pCJ115) expressing
AQR1-GFP under the control of the inducible GAL promoter was isolated by
recombination in yeast between a linearized YCp-GAL-GAP1-GFP plasmid (14)
and the AQR1 coding region obtained by PCR with genomic DNA of wild-type
yeast as template. The recombinant plasmid was purified by cloning into E. coli.
The YCpAQR1-lacZ plasmid contains a lacZ fusion with the promoter region,
the translation initiation codon, and a short portion of the coding region of the
AQR1 gene, from bp 1000 to 33. This construction has been described
elsewhere (62).
TABLE 1. Yeast srains used in this study
Strain Genotype Source or reference
23344c MAT ura3 Laboratory collection
30629c MATa ura3 gap1::kanMX2 36
30633c MATa ura3 gap1::kanMX2 agp1::kanMX2 36
EK041 MAT ura3 gap1 gnp1::kanMX4 This study
JA248 MAT ura3 gap1 gnp1 agp1 This study
FA010 MAT ura3 gap1 ssy1::kanMX4 F. Abdel-Sater and B. Andre´ (unpublished
data)
F4 MATa thr4 S. A. Cruzcampo (Seville, Spain)
-A3hu MAT ura3 hom3 I. Velasco et al. (unpublished data)
IVU41 MAT ura3 thr1::kanMX4 This study
IVU61-1B MATa ura3 gap1 gnp1  agp1  thr1::kanMX4 This study
IVU441 MAT ura3 gap1 agp1 gnp1 hom3::kanMX4 This study
JA324 MAT ura3 aqr1::lacZ-kanMX4 This study
JA316 MAT ura3 qdr3::lacZ-kanMX4 This study
JA310 MAT ura3 qdr1::lacZ-kanMX4 This study
IVU271 MAT ura3 gap1 gnp1 agp1 aqr1::kanMX4 This study
IVU11 MAT ura3 gap1 gnp1 agp1 qdr3::kanMX4 This study
IVU281 MAT ura3 gap1 gnp1 agp1 qdr1::kanMX4 This study
IHI120 Mata ura3 gcn4::LEU2 37
30629a MAT ura3 gap1 36
JA551 MAT ura3 gap1 aqr1-GFP::kanMX This study
JA618 MAT ura3 npi1 aqr1-GFP::kanMX This study
JA629 MAT ura3 gap1 end3 aqr1-GFP::kanMX This study
32600a MAT ura3 gap1 gnp1 agp1 npi1 This study
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Amino acid and methylamine uptake assays. Threonine uptake activities were
determined by measuring incorporation of [14C]Thr in growing cells as described
by Grenson et al. (30, 32). A similar procedure was used to determine uptake of
[14C]methylamine (0.2 mM) in cells growing on proline medium.
HPLC experiments. Cells were grown in minimal liquid medium and harvested
by filtration with a Millipore MF membrane filter (0.45 M) while the medium
was collected. The filters were rinsed and cells were resuspended in distilled
water. Cell suspensions and collected medium were boiled for 15 min and
centrifuged for 10 min at 10,000 	 g to eliminate cellular debris. Supernatants
were then collected, and the concentrations of amino acids were analyzed by
high-performance liquid chromatography (HPLC) as fluorescent derivatives fol-
lowing the Waters AccQ-Tag Instruction Manual (Millipore Corporation, Milford,
Mass.). A chromatographer equipped with a Waters AccQ-Tag column, an
automatic injector (Waters 715 Ultra Wisp), and a scanning fluorescence detec-
tor (Waters 474) were used. Data integration and processing were performed
with the Waters Millennium32 software.
-Galactosidase assays. 
-Galactosidase activities were measured as de-
scribed earlier (4) and are expressed in nanomoles of o-nitrophenol formed per
minute per milligram of protein. Protein concentrations were measured with the
Folin reagent and the standard used was bovine serum albumin. In the experi-
ment of Fig. 7A, the influence of the presence of several other amino acids (2
mM final concentration) was tested. These amino acid were arginine, alanine,
aspartate, cysteine, glycine, histidine, isoleucine, leucine, lysine, methionine,
phenylalanine, serine, threonine, tryptophan, tyrosine, valine, asparagine, citrul-
line, and ornithine. Cytosine and ammonium were also tested.
Fluorescence microscopy. Cells were grown on minimal buffered glucose me-
dium (pH 6.1) with glutamate as the sole nitrogen source and viewed with a
Nikon Eclipse E600 microscope equipped with appropriate fluorescence light
filter sets. Images were captured with a Nikon DXM1200 digital camera and
processed with Adobe Photoshop 5.0 (Adobe Systems, Mountain View, Calif.).
The FL4-64 fluorescent lipid was used to label the vacuolar membrane.
RESULTS
Yeast cells overproducing Thr and Hom do not excrete de-
tectable amounts of either amino acid. Threonine (Thr)-over-
producing mutants of the yeast S. cerevisiae, accumulating up
to 40 times more Thr than the wild-type strain, have been
previously isolated. In all cases studied, overproduction is
linked to mutations in the HOM3 gene causing expression of a
feedback-insensitive aspartate kinase, a key enzyme in the reg-
ulation of the Thr biosynthetic pathway (20, 22, 46). Homo-
serine (Hom), a precursor of Thr biosynthesis, is also overpro-
duced in these HOM3-R mutants (20). We have used a
HOM3-R allele cloned into a centromere-based vector and
tested whether cells transformed with this plasmid excrete de-
tectable amounts of Thr and Hom. For this, we tested whether
HOM3-R cells in drops of high-density cell suspension (5-l
drops of a suspension of108 cells ml1) are able to cross-feed
Thr (thr4) or Hom (hom3) auxotrophs spread at lower den-
sity (150 l of a suspension of 107 cells ml1) on the same
petri dish. The results in Fig. 1 show that neither the thr4 nor
the hom3 auxotroph was efficiently cross-fed by wild-type
cells transformed with HOM3-R, irrespective of whether the
nitrogen source in the medium was proline, NH4
, urea, or
glutamate. Similarly, HOM3-R-transformed cells growing ex-
ponentially in liquid medium (with urea, proline, or NH4
 as
the sole nitrogen source) did not excrete Thr or Hom in de-
tectable amounts (data not shown). On the other hand, wild-
type cells transformed with the HOM3-R gene inserted into a
high-copy-number plasmid excreted low but detectable levels
of Thr into the medium (Table 3). In contrast Hom, present at
a much lower intracellular concentration, was not detected in
the external medium (Table 3).
Previous studies have shown that excretion of amino acids
(30) and nucleobases (29) is more pronounced if the cells are
defective in the uptake of these compounds. We thus sought to
identify the main Thr and Hom permeases in yeast in order to
repeat the above excretion assays with HOM3-R-transformed
cells lacking these permeases.
Identification of Gap1, Agp1, and Gnp1 as the main Thr and
Hom uptake systems in yeast. It has been previously reported
that the general amino acid permease Gap1 and the broad-
specificity amino acid permease Agp1 are involved in Thr up-
TABLE 2. Oligonucleotides used in this study













Plasmid pCJ115 pGal-AQR1 TACCTCTATACTTTAACGTCAAGGAGAAAAAACTATAATGCTACGAAGTAACAGTATATA
pGFP-AQR1 TACTGTTAATTGCTCCAGCACCAGCACCAGCACCTGCTCCATTATGATTATCGTTCTGGT
AQR1-GFP fusion 5-AQR1-GFP CAAAAAGGGAACAAAAAGAGACCAGAACGATAATCATAATGGAGCAGGTGCTGGTGCTGG
3-AQR1-GFP GCAGGGATTATATGCTGAAATTTCCACTGTATATATTTGCGCGGCCGCATAGGCCACTAG
Plasmid plVU13 C5-YNL065w CGCGGATCCGCGATGTCACGAAGTAACAGTATATAC
C3-YNL065w CGCGATATCGCGAATTATGATTATCGTTCTGGTCTC
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take (36, 53). Yet one or more other Thr uptake systems must
exist in yeast, since a gap1 agp1 mutant strain can still grow
on 1 mM Thr as the sole nitrogen source, albeit more slowly
than the wild type (Fig. 2A). Furthermore, the gap1 agp1
and wild-type strains grow similarly on higher Thr concentra-
tions (Fig. 2A). Like Agp1, the additional Thr permeases sus-
taining growth on Thr medium appear to be under the positive
control of the Ssy1 sensor for external amino acids, as the
gap1 ssy1 strain grows more slowly on Thr at low concen-
tration (1 to 3 mM) than the gap1 agp1 strain (Fig. 2A).
Further experiments identified Gnp1 as an additional per-
mease able to mediate Thr uptake and showed that a triple-
mutant gap1 agp1 gnp1 strain is largely defective in incor-
poration of this amino acid. Namely, a gap1 agp1
additionally defective for Gnp1 grew more slowly on a low
concentration of Thr (1 mM) as the sole nitrogen source (Fig.
2A). Furthermore, a low external concentration of Thr was not
able to compensate for a thr1 auxotrophy if this mutation was
present in a gap1 agp1 gnp1 strain (Fig. 2B). Finally, in-
corporation of Thr (0.1 mM) in the gap1 agp1 gnp1 strain
was largely defective (Fig. 3). Other experiments indicated that
besides Gap1, Agp1, and Gnp1, other, lower-affinity, Thr up-
take systems likely exist in yeast. First, slow but significant
residual incorporation of Thr (0.1 mM) was detected in the
gap1 agp1 gnp1 triple-mutant strain (Fig. 3). Second,
growth of the gap1 agp1 gnp1 strain on Thr as the sole
nitrogen source was almost normal when the amino acid was
present at a concentration of 3 mM or more (Fig. 2A). Third,
it remained possible to compensate for a thr1 auxotrophy
introduced into the gap1 agp1 gnp1 strain by adding Thr to
the medium, although it took a higher Thr concentration to do
so than with the thr1 single mutant (Fig. 2B).
We also tested whether Gap1, Agp1, and Gnp1 mediate
Hom uptake. Experiments to directly measure Hom uptake
were not carried out because of the high cost of commercially
available radioactively labeled Hom. We therefore tested
whether Hom could inhibit Thr uptake specifically mediated by
Gap1, Agp1, or Gnp1. In each case, the initial rate of Thr
uptake was markedly reduced if excess Hom was present (Fig.
4) and the kinetic data were consistent with competitive inhi-
bition (not shown). That gap1 agp1 gnp1 cells are largely
defective in Hom uptake was supported by another observa-
tion: a higher external concentration of Hom was needed to
compensate for the hom3 auxotrophy when this mutation was
introduced into the gap1 agp1 gnp1 strain (Fig. 2C).
Yeast gap1 agp1 gnp1 mutant cells overproducing Thr and
Hom excrete both amino acids. As mentioned above, a yeast
mutant defective in high-affinity uptake of a given compound
tends to excrete this molecule into the external medium. This
is particularly true under conditions favoring internal accumu-
lation of the compound (29, 30, 41, 45). We thus tested excre-
tion of Thr and Hom by the gap1 agp1 gnp1 strain defec-
tive in Thr and Hom uptake. The triple-mutant strain was
FIG. 1. Excretion of Hom and Thr by yeast cells grown on solid medium. Cell suspensions of wild-type (23344c) or gap1 agp1 gnp1 (JA248)
strains transformed with the pMACR7 plasmid (HOM3-R) were dropped over a lawn of Thr (thr4; strain F4) or Hom (hom3; strain -A3hu)
auxotroph mutants, and the petri dishes were incubated for 4 days at 29°C. Proline or NH4
 was the sole source of nitrogen in the medium.
TABLE 3. Impact of mutations in GAP1, AGP1, GNP1, and AQR1
genes on intracellular and external Thr and Hom concentrationsa
Strain type
Concn (nmol mg1 [dry wt])
Thr Hom
Intracellular External Intracellular External
Wild type 210.3  18.2 3.2  0.5 39.9  4.4 BDb
gap1 agp1 gnp1 157.1  10.7 45.3  6.4 36.4  4.4 4.4  0.7
aqr1 196.5  19.9 2.2  0.2 30.7  4.9 BD
gap1 agp1 gnp1 aqr1 185.9  9.4 37.0  6.4 29.5  1.9 BD
a Cells transformed with the high-copy-number plasmid containing the
HOM3-R2 allele (pYH3-R2) were grown on minimal medium with proline as the
sole nitrogen source. Intracellular and external concentrations of Thr and Hom
were quantified by HPLC (see Materials and Methods). The average values and
standard deviations obtained from three independent transformed clones are
shown. The Strains were 23344c (wild type), JA324 (aqr1), JA248 (gap1 agp1
gnp1), and IVU271 (gap1 agp1 gnp1 aqr1).
b BD, below detection.
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transformed with the centromeric plasmid bearing the
HOM3-R allele. Feeding of the thr4 strain by the gap1 agp1
gnp1 strain was readily detectable (Fig. 1). This means that a
strain overproducing endogenously synthesized Thr excretes
detectable amounts of Thr into the external medium, provided
the strain is additionally deficient in high-affinity Thr uptake.
This excretion was observed with cells growing on different
nitrogen sources (urea, proline, glutamate, and ammonium)
(Fig. 1) (data not shown). In the case of Hom, the result was
different. Cross-feeding was observed if the cells were grown
on proline, urea, or glutamate medium, but not if they were
grown on ammonium (Fig. 1) (data not shown). The exact
cause of this nitrogen source effect is unknown. A likely expla-
nation is that Hom excreted by gap1 agp1 gnp1 HOM3-R
cells is taken up by surrounding hom3 cells mainly via Gap1,
which is inactive on ammonium but highly active on the other
tested nitrogen sources. Excretion from cells growing on pro-
line medium was confirmed by HPLC amino acid quantifica-
tion (Table 3) (data not shown). In this experiment, HOM3-R
was carried on a high-copy vector to further increase the en-
dogenous production of Thr and Hom. The data show that Thr
excretion by gap1 agp1 gnp1 cells is more pronounced than
that in wild-type cells. Hom was also overproduced in HOM3-R
cells but to lower levels than Thr. In this case, only cultures of
gap1 agp1 gnp1 cells showed some slight excretion of Hom
(Table 3). These data corroborate the growth test data and
further illustrate that amino acid permeases have the capability
to limit excretion of amino acids, most likely by catalyzing their
re-uptake once the amino acids have leaked out of the cell.
Although the cross-feeding tests shown in Fig. 1 have been
carried out using growth media buffered at pH 6.1, net excre-
tion of Hom by the gap1 agp1 gnp1 strain was also observed at
pH 4.5 and 7.0 (data not shown). Curiously, the cross-fed
auxotrophs grew slightly faster around the donor strain on
media at pH 4.5 and 7.0 compared to pH 6.1. Whether these
faster growth phenotypes at pH 4.5 and 7.0 are due to higher
excretion of amino acids by the donor cells, more efficient
incorporation of the excreted amino acids, improved utiliza-
tion of other specific nutrients of the medium, or a combina-
tion of these putative effects will require further investigation.
The YNL065w/AQR1 gene is involved in Hom and Thr excre-
tion. Although the excretion of metabolites by yeast cells has
been illustrated in several previous studies, the transport
mechanisms involved remain poorly known. On the other
FIG. 2. The Gap1, Agp1, and Gnp1 permeases are involved in Thr and Hom utilization. (A) Growth test on increasing concentrations of Thr
as the sole nitrogen source. The strains were 23344c (wild type), 30633c (gap1 agp1), JA248 (gap1 agp1 gnp1), and FA010 (gap1 ssy1). (B) The gap1
agp1 gnp1 mutations reduce the ability of external Thr to complement the growth defect of a Thr auxotroph strain. Cells were grown on minimal
media containing proline or NH4
 as nitrogen source and increasing concentrations of Thr. The strains were 23344c (wild type), IVU41 (thr1),
JA248 (gap1 agp1 gnp1), and IVU61-1B (gap1 agp1 gnp1 thr1). (C) The gap1 agp1 gnp1 mutations reduce the ability of external Hom to complement
the growth defect of a Hom auxotroph strain. Cells were grown on minimal media containing proline or NH4
 as nitrogen source or on YPD
medium. Hom was eventually added to the media at the indicated final concentrations. The strains were JA248 (gap1 agp1 gnp1), -A3hu (hom3),
and IVU441 (gap1 agp1 gnp1 hom3).
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hand, the functions of about 120 of the 282 membrane-trans-
port proteins thus far inventoried in the yeast proteome remain
unknown (3, 64). One might thus speculate that some of these
uncharacterized transporters are in fact involved in excretion,
a transport process that is hard to tackle by the classical genetic
methods usually applied to yeast. Among the proteins poten-
tially involved in the efflux of compounds are the multidrug
transporters of the major facilitator superfamily (28). The mul-
tidrug transporter family includes no less than 23 proteins,
usually viewed as H antiporters because they share high se-
quence similarity with bacterial antibiotic resistance proteins
known to act by this mechanism (57). Several yeast proteins in
this family, such as Flr1p, are clearly involved in drug resis-
tance (1, 9, 39, 50, 61, 63), and the same function has been
proposed for the other members of the family (28, 57). Yet
there is growing evidence that at least some members of this
family are not involved in drug resistance but rather in excre-
tion of natural compounds. For instance, the Dtr1 protein was
recently reported to be specifically expressed during sporula-
tion. It is targeted to the plasma membrane where it mediates
excretion of di-tyrosine, a constituent of the spore cell wall
(23). Similarly, the Tpo1 protein of the same family was re-
cently found to be located at the plasma membrane and to be
involved in the detoxification of excess polyamines (2). Among
the 23 multidrug transporters of the major facilitator super-
family, some are closely related in sequence to the di-ty-
rosine/H exchanger (28, 57). Interestingly, the promoters of
some of these genes (e.g., YBR043C/QDR3) contain an unusu-
ally high number of 5-GATA-3 sequences, a feature typical of
genes sensitive to nitrogen catabolite repression (44). Further-
more, it was recently reported that another gene encoding a
close homologue of Dtr1 (YNL065w/AQR1) is induced by glu-
tamate (43). These observations prompted us to test whether
these putative transporters could play a role in Thr and Hom
excretion. The genes encoding the putative transporters
(AQR1, QDR3, and YIL120w/QDR1) were deleted from the
wild-type strain and from the gap1 agp1 gnp1 triple mu-
tant. The derived strains were transformed with a centrometric
plasmid bearing the HOM3-R allele and used as described
above in cross-feeding tests. Deletion of QDR1 and QDR3 had
no detectable effect on Thr or Hom excretion (not shown), but
deletion of AQR1 completely suppressed the ability of the
gap1 agp1 gnp1 strain to cross-feed hom3 cells (Fig. 5).
This suggests that Aqr1 is essential to Hom excretion. Consis-
FIG. 3. Gap1, Agp1 and Gnp1 are the main Thr uptake systems.
Time course accumulation of [14C]Thr added at time zero at a 0.1 mM
initial concentration to cells growing on minimal medium with proline
(A) or NH4
 (B) as the sole nitrogen source. The strains were gap1 (F,
strain 30629c), gap1 agp1 (, strain 30633c), gap1 gnp1 (E, strain
EK041), and gap1 agp1 gnp1 (, strain JA248).
FIG. 4. Hom inhibits Gap1, Agp1, and Gnp1 uptake activities. (A) Initial velocity of 0.1 mM [14C]Thr uptake in wild-type (E, F) and gap1 (	)
strains. The cells were grown on minimal proline medium, and Hom (10 mM final concentration) was added (E) or not (F, 	) to the medium at
time zero of the experiment. (B) Initial velocity of 0.1 mM [14C]Thr uptake in gap1 gnp1 (E, F) and gap1 agp1 gnp1 (	) strains. The cells were
grown on minimal proline medium to which citrulline (5 mM final concentration) was added 30 min before the uptake assay to induce AGP1
transcription. Hom (10 mM final concentration) was added (E) or not (F, 	) to the medium at time zero of the experiment. (C) Initial velocity
of 0.1 mM [14C]Thr uptake in gap1 agp1 (E, F) and gap1 agp1 gnp1 (	) strains. The cells were grown on minimal NH4
 medium to which citrulline
was added (5 mM final concentration) 30 min before the uptake assay to induce GNP1 transcription. Hom (10 mM final concentration) was added
(E) or not (F, 	) to the medium at time zero of the experiment. The strains were 23344c (wild type), 30629c (gap1), 30633c (gap1 agp1), EK041
(gap1 gnp1), and JA248 (gap1 agp1 gnp1).
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tently, HPLC measurements in liquid cultures showed that the
aqr1mutation prevents excretion of Hom by the gap1 agp1
gnp1 strain (Table 3). Furthermore, the effect of the aqr1
mutation does not seem to be due to impaired endogenous
synthesis of Hom (Table 3). A lack of Aqr1 also reduced
cross-feeding of the thr4 auxotroph, but this effect was not as
pronounced as with hom3 cells and varied in intensity from
one experiment to the other (data not shown) (see Fig. 8B). In
conclusion, our data indicate that Aqr1 is an essential compo-
nent of Hom excretion. Although it appears also to also con-
tribute to Thr excretion, other excretion systems for this amino
acid likely exist.
The apparent role of Aqr1 in Hom and Thr excretion could
be indirect: e.g., lack of Aqr1 could affect the electrical plasma
membrane potential. However, we could not see any effect of
the aqr1 mutation on the ability of cells to incorporate meth-
ylammonium neither on their sensitivity to toxic concentrations
of hygromycin B, tetramethylammonium, or lithium chloride
(data not shown) (see Materials and Methods). These obser-
vations make it unlikely that Aqr1 affects amino acid excretion
by altering the potential of the plasma membrane.
Overexpression of Aqr1 leads to excretion of amino acids,
including aspartate, glutamate, and alanine. The above data
show that Aqr1 is involved in excretion of Hom. We next
addressed the following question: can Aqr1 mediate efflux of
other amino acids? We overexpressed the AQR1 gene in a
gap1 agp1 gnp1 aqr1 strain producing normal levels of
Thr and Hom (not transformed with the HOM3-R plasmid)
and measured the release of amino acids into the growth me-
dium. For this, we placed the AQR1 behind the regulatable Tet
promoter in a high-copy-number vector and used the resulting
plasmid to transform gap1 agp1 gnp1 aqr1 cells. The cells
were grown on a minimal medium devoid of amino acids and
containing NH4
 as the sole nitrogen source. To this medium,
doxycycline, an antibiotic relieving repression of Tet promoter-
dependent expression of AQR1, was added or not. The growth
media were collected 22 h after derepression of AQR1 expres-
sion and subjected to HPLC analysis (Fig. 6). Many amino
acids (e.g., arginine, leucine, phenylalanine, glutamine, lysine,
and isoleucine) were undetectable in the external medium,
regardless of whether AQR1 was expressed or not (not shown).
Aspartate, remarkably, was detected only in the medium of
cells overexpressing AQR1. Hence, Aqr1 would appear to me-
diate excretion of this amino acid also. Many other amino acids
were detected in the medium of cells that were not expressing
Aqr1, but AQR1 overexpression caused a net increase in the
external concentration of several of them. The effect was more
pronounced for glutamate and alanine (Fig. 6). Interestingly,
FIG. 5. AQR1 is required for Hom excretion. Cell suspensions of wild-type (23344c), gap1 agp1 gnp1 (JA248), and gap1 agp1 gnp1 aqr1
(IVU271) strains transformed with the pMACR7 plasmid (HOM3-R) were dropped over a lawn of Hom (hom3, strain -A3-hu) auxotroph
mutants and the petri dishes were incubated for 4 days at 29°C. Proline was the sole source of nitrogen in the medium.
FIG. 6. AQR1 is involved in excretion of aspartate, alanine, and
glutamate. Cells of the gap1 agp1 gnp1 aqr1 strain (IV271) transformed
with the 2m plasmid pIVU13 (Tet-AQR1) were grown on minimal
medium containing NH4
 as the sole nitrogen source plus doxycycline
to repress AQR1 transcription. At time zero of the experiment (early
exponential phase, 0.2 to 0.4 mg of dry weight ml1), the culture was
filtered and cells were resuspended in the same medium with (Aqr1
not expressed) or without (Aqr1 expressed) doxycycline. Cells were
harvested after 22 h, i.e., at late-exponential/early-stationary phase (1
to 2 mg of dry weight ml1), and the concentrations of free amino acids
inside cells (int.) and in the external medium (ext.) were measured by
HPLC as detailed in Materials and Methods. Data are shown for
aspartate (Asp), glutamate (Glt), alanine (Ala), glycine (Gly), Thr, and
valine (Val).
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these amino acids (Glu, Ala, and Asp) are precisely those
reported to be present at the highest concentrations in the
cytosol of cells growing on glucose-ammonium medium (48).
Other amino acids (e.g., arginine, ornithine, histidine, and glu-
tamine) are present at high levels in cells growing under these
conditions, but these are found mostly in the vacuole.
These results thus show that in cells where no amino acid is
overproduced, overexpression of the AQR1 gene leads to a
significant increase in Asp, Glu, and Ala excretion. Aqr1-de-
pendent excretion was most pronounced for Glu and Ala, the
two amino acids present at the highest concentrations in the
cytosol (48). Yet both amino acids were also excreted by cells
not expressing Aqr1. This suggests the involvement of other
export systems or mechanisms. In the case of Asp, no excretion
was detected when Aqr1 was not expressed, suggesting that
Aqr1 is the main Asp excretion system under the conditions
tested. These results, together with those obtained with cells
overproducing Thr and Hom, suggest that the role of Aqr1
could be to mediate excretion of amino acids present at high
concentrations in the cytosol.
Analysis of AQR1 gene expression. Given the role of Aqr1 in
the excretion of several amino acids, we sought to determine
whether expression of the AQR1 gene is influenced by levels of
amino acids in the medium. To test this, we constructed a
plasmid bearing the lacZ gene under the control of the AQR1
gene’s promoter. We introduced the plasmid into wild-type
cells and monitored 
-galactosidase activity in transformed
cells growing on minimal medium devoid of amino acids or to
which a single amino acid was added (see Materials and Meth-
ods). A significant level of AQR1-lacZ expression was observed
in urea-grown cells, and expression was higher if -amino-n-
butyric acid (GABA; approximately four- to fivefold), gluta-
mate (five- to sixfold), or proline (three- to fourfold) was also
present in the medium (Fig. 7A). Other amino acids had no
significant effect on AQR1-lacZ expression (not shown). The
higher expression of AQR1 on urea-plus-glutamate medium
corroborates previous whole-genome transcription analysis
data showing that AQR1 is one of the many genes that are
induced by glutamate (43).
Analysis of the AQR1 promoter revealed that it contains
several perfect matches to the consensus binding site for the
Gcn4 transcription factor. We thus tested whether AQR1 is
under Gcn4 control. The plasmid bearing the AQR1-lacZ gene
was introduced into wild-type and gcn4 strains, and trans-
formed cells were grown on urea or ammonium medium. The
results of 
-galactosidase assays unexpectedly revealed that
AQR1 expression is three- to fourfold higher in the gcn4
mutant than in the wild type (Fig. 7B), thus suggesting that
Gcn4 exerts a negative control on AQR1 expression. Gcn4 is
known to be more active when the internal level of any one of
several amino acids is reduced (34). That an AQR1-lacZ gene
is more highly expressed in a gcn4 strain might thus be ratio-
nalized as a mechanism limiting amino acid excretion under
conditions of amino acid privation.
Aqr1 is mainly intracellular and transits constantly through
the plasma membrane. We next examined the subcellular lo-
cation of Aqr1. For this, the GFP preceded by a linker was
fused in frame to the extreme C terminus of Aqr1. Remark-
ably, in cells expressing the fusion gene under the control of
the natural AQR1 promoter, the fluorescence was weak in
intensity and mainly present in multiple small punctate struc-
tures distributed in the whole cytoplasm (Fig. 8A) In at least
some cells, a weak fluorescent signal was also detectable at the
cell surface. The internal subcellular location pattern of Aqr1
differed from the one reported for proteins located in the
endoplasmic reticulum, Golgi, or endosomes and is more com-
patible with a location in multiple internal vesicles. As a small
fraction of the protein appears also located at the cell surface
in some cells, we addressed the question of whether Aqr1
cycles between the internal and the plasma membranes. We
thus examined the location of Aqr1-GFP in mutant strains
defective in endocytosis. We first used the npi1/rsp5 strain in
which endocytosis of multiple plasma membrane proteins was
shown to be defective. This endocytosis defect is caused by a
mutation reducing the level of the HECT-type ubiquitin ligase
Rsp5, a protein involved in ubiquitylation and subsequent en-
docytosis of a wide variety of plasma membrane transporters
(56). In the npi1/rsp5 mutant expressing Aqr1-GFP, the fluo-
rescence was mainly redistributed to the cell surface (Fig. 8A).
A similar location was observed in the end3 strain, another
classically used mutant defective in endocytosis (52). These
data strongly suggest that Aqr1 constantly cycles between mul-
tiple internal membranes and the cell surface. Furthermore,
endocytosis of Aqr1 is apparently dependent on a normal Rsp5
ubiquitin ligase function. Other yeast proteins were reported to
cycle constantly between the cell surface and internal mem-
branes: e.g., the Snc1 SNARE protein (42). When expressed
above normal levels, Snc1 tends to accumulate mostly at the
cell surface. Interestingly, the same was observed when Aqr1-
GFP was overexpressed (e.g., by placing its gene under the
control of the GAL promoter), with a fraction of the protein
being targeted to the endosome/vacuolar degradation pathway
(62; our unpublished data). Finally, we tested whether the npi1
mutation provoking accumulation of Aqr1 at the plasma mem-
FIG. 7. Expression of an AQR1-lacZ fusion gene. (A) Cells of the
wild-type strain (23344c) transformed with the YCpAQR1-lacZ plas-
mid were grown on minimal medium with urea as the sole nitrogen
source. At time zero of the experiment, the indicated amino acids were
added at a 2 mM final concentration. After 2 h, cells were collected
and 
-galactosidase activity was assayed as described in Materials and
Methods. (B) Cells of the wild type (23344c) and gnc4 mutant (IHI120)
transformed with the YCpAQR1-lacZ plasmid were grown on minimal
medium containing urea as the sole nitrogen source. 
-Galactosidase
activity was assayed as described in Materials and Methods.
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brane affects Aqr1’s ability to mediate excretion of Hom and Thr.
The results revealed that the npi1 mutation markedly reduced the
ability of the gap1 agp1 gnp1 excretor strain to cross-feed the
Hom and Thr auxotroph strains (Fig. 8B). This suggests that Aqr1
is most active as an amino acid excretion protein when located in
internal membranes. As discussed below, this observation sup-
ports the model according to which Aqr1 functions by loading
internal vesicles with amino acids, which are then released into
the external medium by exocytosis.
DISCUSSION
Yeast cells can excrete metabolites such as amino acids. This
occurs under particular conditions, e.g., when the amino acid is
produced at abnormally high levels as a result of deregulated
anabolism or when amino acid metabolism rapidly shifts to an
imbalanced situation (30). The mechanisms of this excretion
remain unknown. It is highly interesting to investigate the
molecular details of this cell process in yeast, because amino
acid excretion exists in other eukaryotes as well. For instance,
plants often associate with mycorrhizal fungi whose expanding
mycelium scavenges nitrogen from the surrounding soil. This
nitrogen is then transmitted to the plant in the form of amino
acids through export mechanisms which remain unknown (11).
Transfer of amino acids between tissues of pluricellular organ-
isms such as plants involves rounds of transport out of and into
the cell, but the proteins involved in amino acid export remain
uncharacterized (51). Yeast mutants defective in excretion of
specific amino acids might thus be used as recipient strains to
characterize genes involved in amino acid excretion in other
species.
Efflux of an amino acid may be catalyzed by an energy-driven
carrier located at the plasma membrane. Several amino acid
exporters of this type have indeed been characterized in bac-
teria (16). In eukaryotes, excretion of metabolites can in prin-
ciple also be mediated by exocytosis. In this case, the com-
pound must first be incorporated into vesicles via transporters
located in the vesicle membranes. For instance, several vesic-
ular transporters responsible for the loading of synaptic vesi-
cles with neurotransmitters have been characterized in animals
(17). These proteins act as H antiporters, the H gradient
being established by V-type H-ATPases responsible for the
acidification of internal membrane compartments (65).
In this study, we have defined a methodology for investigat-
ing the excretion of specific amino acids in yeast. We used cells
artificially overproducing Thr and Hom as a result of a domi-
nant HOM3-R allele. As these cells growing in standard growth
media did not excrete much Hom or Thr into the medium, we
sought to identify the genes coding for the main uptake sys-
tems for these amino acids in yeast, since reports suggest that
excretion of a given compound is often more pronounced in
cells defective in high-affinity uptake of that compound. This is
probably because influx systems catalyze re-uptake of the ex-
truded compound (31). We thus found that three amino acid
permeases, Gap1, Agp1, and Gnp1, are the main Thr and Hom
uptake systems in yeast. When Hom and Thr were overpro-
duced in the triple gap1 agp1 gnp1 mutant strain, we detected
net excretion of both amino acids into the medium. This ex-
cretion was observed on solid media in cross-feeding tests and
in liquid media by HPLC measurements. Starting with this
strain, we then applied a reverse-genetics approach to test
candidate genes possibly involved in Thr and Hom excretion. A
similar strategy could be applied to identify genes involved in
other metabolite excretion processes. For instance, mutant al-
leles or genetic strategies causing abnormal accumulation of
many different metabolites have been described, and the main
yeast permeases involved in the uptake of most natural nutri-
tional compounds (sugars, amino acids, phosphate, nucleo-
bases, vitamins, etc.) are known (64). It should thus be possible
to construct yeast strains overproducing and excreting a large
set of specific metabolites. These strains could then be used to
search for genes involved in metabolite excretion, such genes
having largely eluded characterization by standard methods.
Using this approach, we found that the AQR1 gene is in-
FIG. 8. Mutations impairing endocytosis affect Aqr1 subcellular loca-
tion and Aqr1-mediated excretion of amino acids. (A) Subcellular loca-
tion of an Aqr1-GFP fusion protein. Cells of the JA551 (AQR1-GFP
ura3), JA618 (AQR1-GFP npi1 ura3), and JA629 (AQR1-GFP end3
ura3) strains were grown on minimal glutamate medium and examined by
fluorescence microscopy. Cells were labeled with FM4-64 to stain the
vacuolar membrane and endosomal compartments (not shown). (B) Cell
suspensions of wild-type (23344c), gap1 agp1 gnp1 (JA248), gap1 agp1
gnp1 aqr1 (IVU271), and gap1 agp1 gnp1 npi1 (32600a) strains trans-
formed with the pMACR7 plasmid (HOM3-R) were dropped over a lawn
of Thr (thr4, strain F4) or Hom (hom3, strain-A3hu) auxotroph mutants
and the petri dishes were incubated for 4 days at 29°C. Glutamate was the
sole source of nitrogen in the medium.
1500 VELASCO ET AL. EUKARYOT. CELL
 o
n








volved in excretion of amino acids. Several results support this
conclusion. First, Hom and Thr excretion by the overproducing
strain is impaired if the AQR1 gene is deleted, and this loss of
excretion is not caused by reduced endogenous synthesis of the
amino acids. Second, if Aqr1 is overexpressed in cells defective
in the uptake of multiple amino acids, aspartate is excreted
into the medium; this phenomenon is not observed if Aqr1 is
not expressed. Furthermore, a net increase in excretion of two
other amino acids (i.e., glutamate and alanine) occurs when
Aqr1 is overexpressed. Interestingly aspartate, glutamate, and
alanine are the most abundant amino acids in the cytosol of
cells growing under the tested conditions. Our results thus
suggest that the normal role of Aqr1 might be to catalyze
excretion of amino acids present at relatively high levels in the
cytosol. This process could (e.g., by providing a mechanism for
protecting cells against the accumulation of amino acids to
toxic levels). That the normal function of Aqr1 is indeed to
mediate amino acid excretion is supported by the observation
that transcription of the AQR1 gene is influenced by amino
acids. Hence, as previously reported on the basis of a genome-
wide transcriptome analysis (43), AQR1 transcription is in-
duced severalfold by glutamate. Two other amino acids, pro-
line and GABA, also promote higher-level expression of
AQR1. Why these amino acids (and not other ones) increase
AQR1 transcription, however, requires further investigation.
The AQR1 gene is also expressed to a higher level in a gcn4
strain characterized by defective general control of amino acid
biosynthesis control. Although this might in principle be an
indirect effect of the internal pool of amino acids, the presence
of several potential binding sites for Gcn4 in the AQR1 gene
promoter suggests that AQR1 could be a direct target gene of
Gcn4. Many yeast genes are reported to be under the negative
control of Gcn4 (49). Lower expression of AQR1 in cells de-
prived of one or several amino acids (conditions under which
Gcn4 is active) is consistent with a role of Aqr1 amino acid
excretion. Yet our data do not rule out another possibility: that
the main physiological role of Aqr1 might be to mediate ex-
cretion of compounds other than amino acids, e.g., amino acid
derivatives, recognizing amino acids also but less efficiently and
only when they are present at unusually high levels. It was also
previously reported that Aqr1 confers a moderate increase of
yeast tolerance to toxic concentrations of ketoconazole, the
cationic dye crystal violet, and short-chain monocarboxylic ac-
ids (62). We favor the view that the potential recognition by
Aqr1 of these toxic compounds corresponds to opportunistic
side effects of Aqr1’s natural function, which is to mediate
excretion of amino acids (and possibly amino acid derivatives).
Our data also show that Aqr1 is not the sole yeast protein
involved in amino acid excretion. For instance, cells lacking
Aqr1 are able to excrete glutamate and alanine. Furthermore,
excretion of Thr still occurs in the aqr1 mutant, and cross-
feeding tests have even shown that a cell lacking Aqr1 can
excrete some Hom when the level of this amino acid is very
high: i.e., when the HOM3-R gene is introduced on a high-copy
vector (our unpublished data). The Aqr1 protein is part of the
large MFS protein family (57). Several members of this family
(e.g., Flr1) are clearly involved in drug resistance, and consis-
tently, their genes are under the control of the PDR transcrip-
tional network (15). Yet the functions of many other proteins
of this family remain unknown, and their genes are apparently
not under PDR control (15, 57). It is thus tempting to specu-
late that close homologues of Aqr1 might be involved in ex-
cretion of amino acids or derivatives. In support of this view,
one such protein (Dtr1) is specifically expressed during sporu-
lation, and catalyzes excretion of di-tyrosine, a component of
the spore cell wall (23). Furthermore, a gene encoding another
close homologue of Aqr1 (YBR043c/QDR3) is under nitrogen
control (our unpublished observations). Several of these genes
could be singly deleted without detectably altering Thr or Hom
excretion in cross-feeding tests. As many transporters in yeast
display partial functional redundancy, we are currently inves-
tigating the impact of deleting several genes closely related to
AQR1 on the excretion of Hom, Thr, and other amino acids as
well.
A central question emerging from this work is through which
mechanism does Aqr1 favor amino acid excretion? The protein
(586 amino acids) is predicted to be made of 12 transmem-
brane domains flanked by N- and C-terminal hydrophilic tails
and shares highly significant sequence similarity with several
MFS drug resistance proteins (from bacteria and fungi) most
likely acting as H antiport systems. Interestingly, when com-
pared against the entire set of human proteins, Aqr1 exhibits
the highest degree of similarity with members of the VAT
family (18). The VAT proteins are in fact similar to many
bacterial and fungal MFS proteins of the multidrug resistance
family (60). These proteins are expressed in secretory vesicles
in neuronal and endocrine cells. They function as H antiport-
ers and catalyze the transport of acetylcholine and biogenic
amines into the secretory vesicles which then release them into
the extracellular space by exocytosis. When expressed under
the natural AQR1 gene promoter, an Aqr1-GFP fusion is
present in multiple membrane compartments dispersed
throughout the cytoplasm. Furthermore, we have provided ev-
idence that, under these conditions, Aqr1 constantly cycles
between these internal membranes and the cell surface. These
observations suggest two possible models of Aqr1 function.
According to one model, Aqr1 would be active at the plasma
membrane as an amino acid/H exchanger. Its constant cycling
between the plasma and internal membranes could provide a
means of controlling its activity. Yet we have studied the sub-
cellular location of Aqr1 under different growth conditions
(e.g., by varying amino acid availability) and have found no
conditions favoring higher accumulation of Aqr1 at the cell
surface. According to the second model, Aqr1 would be natu-
rally present in the membrane of intracellular vesicles and
would act mainly as an amino acid/H antiporter to load these
vesicles with amino acids present at relatively high concentra-
tion in the cytosol. The amino acids would then be released
into the external medium by exocytosis. The Aqr1 protein
having reached the plasma membrane through exocytosis
would then be rapidly internalized back to internal vesicles,
and this would require prior ubiquitylation of the transporter,
as shown for endocytosis of many plasma membrane proteins.
In support of this model, we found that accumulation of Aqr1
at the cell surface by means of the npi1/rsp5 mutation also
reduces the ability of cells to mediate Aqr1-dependent excre-
tion of amino acids. This second model thus implies that exo-
cytosis would be the main mechanism through which amino
acids are excreted in yeast. A similar model has recently been
proposed for auxin transport in plants. Auxin is a derivative of
VOL. 3, 2004 YEAST Aqr1 MEDIATES EXCRETION OF AMINO ACIDS 1501
 o
n








tryptophan acting as a key plant growth hormone. Polar cell-
to-cell transport of auxin requires an auxin-H antiporter
(Pin1). Although Pin1 was initially viewed as a carrier mediat-
ing active export of auxin across the plasma membrane, current
data (25, 26) are also consistent with a role of Pin1 in loading
auxin into plasma-derived endosomal and endosome-recycling
vesicles. In other words, auxin might be released from plant
cells by exocytosis (6).
In yeast, bulk excretion of several compounds present in
excess concentration in the cytosol (e.g., primary and second-
ary metabolites, ions, etc.) might thus be at least partially
mediated by the concerted action of vesicular H antiporters
and exocytosis. Plasma membrane uptake systems could then
possibly catalyze the selective re-uptake of compounds useful
for cell metabolism. Under specific nutrient supply conditions,
for instance, the high-affinity Gap1 permease efficiently limits
excretion of several amino acids (our unpublished data) and
the high-affinity Mep1 and Mep2 permeases limit that of am-
monium (45). Release of molecules via exocytosis provides an
obvious means of preventing excess accumulation of com-
pounds in the cytosol. This cell function might have then
evolved into systems mediating cell-to-cell communication, as
for neurotransmitter in the case of animals, possibly for auxin
in the case of plants, and why not also in fungi when growing
as multicellular hyphae or pseudohyphae?
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